Skip to content

Study · Not a test of the peptide alone · 1994

1 result

Interaction of plant profilin with mammalian actin.

Giehl K, Valenta R, Rothkegel M, Ronsiek M, Mannherz HG, Jockusch BM

European journal of biochemistry1 Dec 1994Cited by 53 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Other

    In cross-linking experiments, birch profilin competed with thymosin beta‑4 for actin binding but had no effect on gelsolin segment 1 binding.

    In plain wordsIn lab tests, plant profilin competed with thymosin beta‑4 for binding to actin. The result is about profilin, not thymosin beta‑4 itself.

    Outcome
    Not applicableProfilin competition with thymosin beta 4 for actin
    Study

    n: not reported in source

    Cross-linking of actin with birch profilin, thymosin beta 4 and gelsolin segment 1
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    Cross-linking experiments with actin, birch profilin, the G-actin binding peptide thymosin beta 4 and gelsolin segment 1, the N-terminal fragment of an actin capping protein, showed that profilin competed with thymosin beta 4, but had no effect on segment 1 binding to actin.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.